TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,251,207 | 906,211 | 781,609 |
Financial expenses | 1,159 | 29 | 72 |
Earnings before taxes | 672,573 | 601,916 | 496,412 |
EBITDA | 669,081 | 601,839 | 496,448 |
Total assets | 867,981 | 562,777 | 634,993 |
Current assets | 853,998 | 488,995 | 561,728 |
Current liabilities | 125,924 | 65,782 | 70,570 |
Equity capital | 731,833 | 491,129 | 562,654 |
- share capital | 9,743 | 10,045 | 10,790 |
Employees (average) | 46 | 29 | 29 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.3% | 87.3% | 88.6% |
Turnover per employee | 27,200 | 31,249 | 26,952 |
Profit as a percentage of turnover | 53.8% | 66.4% | 63.5% |
Return on assets (ROA) | 77.6% | 107.0% | 78.2% |
Current ratio | 678.2% | 743.4% | 796.0% |
Return on equity (ROE) | 91.9% | 122.6% | 88.2% |
Change turnover | 372,232 | 178,603 | 58,362 |
Change turnover % | 42% | 25% | 8% |
Chg. No. of employees | 17 | 0 | 1 |
Chg. No. of employees % | 59% | 0% | 4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.